hellozdrowie.pl Overview

Alexa Rank
108,509

Daily Pageviews per Visitor
1.0

Daily Time on Site
1:36

Bounce Rate
92.1%

Search Traffic
43.9%

Total Sites Linking In
278
Traffic Statistics
Audience Geography
Visitors by Country | Site Traffic |
---|---|
Poland |
87.5% |
Germany |
4.2% |
Switzerland |
1.4% |
Rankings by Country | Alexa Rank # |
---|---|
Poland |
1,048 |
Germany |
54,247 |
Switzerland |
22,004 |
Keyword Analysis
Top Keywords
Top Keywords | Search Traffic |
---|---|
add |
0.65% |
tre |
0.63% |
opatrunek okluzyjny |
0.55% |
mcv wysokie |
0.54% |
ból kości kciuka |
0.53% |
Audience Report
Audience Overlap
Similar sites that share the same visitors and search keywords with this site.
Similar Sites | Alexa Rank |
---|---|
6,222 | |
147,525 | |
38,833 | |
188,800 | |
130,308 |
Keyword Opportunities
Keyword Gaps
Keyword | Competitors Traffic |
Search Popularity |
---|---|---|
rdw-cv |
41 | 36 |
ph moczu |
41 | 11 |
erytrocyty w moczu |
40 | 14 |
rdw cv |
38 | 29 |
These keywords are driving traffic to competitors, but not to this site.
Easy-to-Rank Keywords
Keyword | Relevance to this site |
Search Popularity |
---|---|---|
kreatynina |
61 | 22 |
przepuklina pachwinowa |
51 | 16 |
leukocyty w moczu |
58 | 21 |
dna moczanowa |
58 | 25 |
These are popular keywords within this site's competitive power.
Buyer Keywords
Keyword | Competitors Traffic |
Organic Competition |
---|---|---|
psa free |
15 | 59 |
alkomat online |
12 | 42 |
moderna vs pfizer |
10 | 66 |
pfizer vs johnson and johnson |
10 | 66 |
These keywords show a high purchase intent.
Optimization Opportunities
Keyword | Search Popularity |
Organic Share of Voice |
---|---|---|
homeostaza |
19 | 4.15% |
internista |
23 | 3.01% |
ast |
51 | 0.06% |
rozrusznik serca |
14 | 4.2% |
These are very popular keywords that are already driving some traffic to this site.
Competitive Analysis
Websites | Search Traffic |
---|---|
80.1% | |
77.3% | |
70.5% | |
43.9% | |
35.6% |
Website | Referral Sites |
---|---|
863 | |
278 | |
242 | |
157 | |
62 |
Copyright © 2025 AlreadyCoded